| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |